Close Menu

equity investment

GeneNews has signed a binding agreement with multinational private equity firm Milost Global for up to $10 million in equity and debt financing.

SOL will help Personal Genomics to further develop its research projects and implement its new facility dedicated to DNA sequencing.

The Irish firm plans to launch the OncoMasTR prognostic test in 2018.

The firm will sell 855,000 shares of its common stock to three investors. It will also sell warrants to the same investors.

The rapid point-of-care diagnostics company anticipates receiving CE marking for its breast cancer test by March and launching it in India shortly afterward. 

Bio-Techne said that the investment gives it a strategic foundation in diagnostics and greater access to end customers.

The Norwegian microbiome-focused clinical diagnostics company has ceded commercialization rights in certain undisclosed territories to Bio-Rad as part of the deal.